TATVA CHINTAN PHARMA CHEM LTD.
NSE : TATVABSE : 543321ISIN
CODE : INE0GK401011Industry : ChemicalsHouse
: Private
BSE1241.100.85 (+0.07 % )
PREV CLOSE (Rs.) 1240.25
OPEN PRICE (Rs.) 1226.95
BID PRICE (QTY) 1235.45 (4 )
OFFER PRICE (QTY) 1240.20 (13 )
VOLUME 117
TODAY'S LOW / HIGH (Rs.)
52 WK LOW / HIGH (Rs.)
NSE1238.00 -1.9 (-0.15 % )
PREV CLOSE(Rs.) 1239.90
OPEN PRICE (Rs.) 1239.90
BID PRICE (QTY) 1236.70 (1 )
OFFER PRICE (QTY) 1237.95 (1 )
VOLUME 915
TODAY'S LOW / HIGH(Rs.)
52 WK LOW / HIGH (Rs.)
Company News
| Date | Heading | Details |
|---|---|---|
| 16-Mar-2024 | Tatva Chintan Pharma Chem submits analyst meet intimation | <div style="text-align: justify;">Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended, Tatva Chintan Pharma Chem has submitted schedule of investor meeting that the Company would be participating. Date: 21 March 2024. The Company will be referring to publicly available information for discussions during interaction in the meeting. No confidential / unpublished price sensitive information (UPSI) will be shared during the meeting. The above information shall be made available on the website of the Company at www.tatvachintan.com.</div><div style="text-align: justify;"><br></div><div style="text-align: justify;">The above information is a part of company's filings submitted to BSE. </div><div style="text-align: justify;"><br></div> |
| 27-Jan-2024 | Tatva Chintan Pharma Chem informs about update | <div>Pursuant to Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 as amended, Tatva Chintan Pharma Chem has informed that it has revamped its website, www.tatvachintan.com, which is more user and Investor friendly.</div><div><br></div><div>The above information is a part of company's filings submitted to BSE.</div><div><br></div> |
| 17-Jan-2024 | Tatva Chintan Pharma Chem informs about earnings call | <p style="text-align: justify;">Pursuant to Regulation 30(6) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended, Tatva Chintan Pharma Chem has informed that the Earnings Call post announcement of financial results of the Company for the quarter and nine months ended 31st December 2023, is scheduled on Saturday, 20 January 2024 at 04:00 pm (IST). The Call is hosted by ICICI Securities and an invite in this regard is attached. The above information is also being made available on the website of the Company at https://www.tatvachintan.com/.</p><p style="text-align: justify;"><span style="text-align: left;">The above information is a part of company's filings submitted to BSE.</span></p> |
| 08-Sep-2023 | Tatva Chintan Pharma Chem informs about disclosure | <div style="text-align: justify;">Tatva Chintan Pharma Chem has informed that the Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Shekhar Rasiklal Somani.</div><div style="text-align: justify;"><br></div><div style="text-align: justify;">The above information is a part of company's filings submitted to BSE.</div><div style="text-align: justify;"><br></div> |
| 07-Sep-2023 | Tatva Chintan Pharma Chem informs about disclosure | <div style="text-align: justify;">Tatva Chintan Pharma Chem has informed about filing of Report under Regulation 29(2) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011 of Ajay Mansukhlal Patel, member of Promoter/ Promoter Group.</div><div style="text-align: justify;"><br></div><div style="text-align: justify;">The above information is a part of company's filings submitted to BSE.</div> |
| 05-Aug-2023 | Tatva Chintan Pharma Chem informs about newspaper publication | <div style="text-align: justify;">Pursuant to regulation 30 and 47 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended, Tatva Chintan Pharma Chem has informed that it enclosed copies of newspaper publication of extract of financial results of the Company for the quarter ended 30 June 2023, published in Financial Express (English edition) and Vadodara Samachar (Gujarati edition) on 05 August 2023. The above information shall be made available on the website of the Company at www.tatvachintan.com</div><div style="text-align: justify;"><br></div><div style="text-align: justify;">The above information is a part of company's filings submitted to BSE.</div> |
| 06-May-2023 | Tatva Chintan Pharma Chem informs about newspaper publication | <p style="text-align: justify;">Pursuant to regulation 30 and 47 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended, Tatva Chintan Pharma Chem has informed that it enclosed copies of newspaper publication of extract of financial results of the Company for the quarter and financial year ended 31 March 2023, published in Financial Express (English edition) and Vadodara Samachar (Gujarati edition) on 06 May 2023. The above information shall be made available on the website of the Company at www.tatvachintan.com.</p><p style="text-align: justify;">The above information is a part of company's filings submitted to BSE.</p><div style="text-align: justify;"><br></div> |
| 05-May-2023 | Tatva Chintan Pharma Chem board approves dividend | <div style="text-align: justify;">Tatva Chintan Pharma Chem has informed that the Board Recommended a Final Dividend of Rs 2 (20%) per equity share of Rs 10 each fully paid (subject to deduction of tax, if any) on the equity share capital of Rs 22,16,50,620 (2,21,65,062 equity shares of Rs 10 each) for the financial year 2022-23. This shall be paid subject to the approval of the shareholders at the ensuing Annual General Meeting of the Company.</div><div style="text-align: justify;"><br></div><div style="text-align: justify;">The above information is a part of company's filings submitted to BSE.</div> |
| 05-May-2023 | Tatva Chintan Pharma Chem informs about press release | <div>Tatva Chintan Pharma Chem has informed that it enclosed a copy of the Press Release on financial results of the Company for the quarter and financial year ended 31 March 2023. The above information shall be made available on the website of the Company at www.tatvachintan.com.</div><div><br></div><div>The above information is a part of company's filings submitted to BSE.</div><div><br></div> |
| 04-May-2023 | Tatva Chintan Pharma Chem informs about disclosure | <p style="text-align: justify;">Tatva Chintan Pharma Chem has informed that the exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Nippon Life India Trustee.</p><p style="text-align: justify;">The above information is a part of company's filings submitted to BSE.</p><div><br></div> |
